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ABSTRACT
Background Lateral ankle sprains are common in 
indoor sports. High shoe–surface friction is considered a 
risk factor for non- contact lateral ankle sprains. Spraino 
is a novel low- friction patch that can be attached to the 
outside of sports shoes to minimise friction at the lateral 
edge, which could mitigate the risk of such injury. We 
aimed to determine preliminary effectiveness (incidence 
rate and severity) and safety (harms) of Spraino to 
prevent lateral ankle sprains among indoor sport 
athletes.
Methods In this exploratory, parallel- group, two- arm 
pilot randomised controlled trial, 510 subelite indoor 
sport athletes with a previous lateral ankle sprain were 
randomly allocated (1:1) to Spraino or ’do- as- usual’. 
Allocation was concealed and the trial was outcome 
assessor blinded. Match and training exposure, number 
of injuries and associated time loss were captured 
weekly via text messages. Information on harms, fear- of- 
injury and ankle pain was also documented.
Results 480 participants completed the trial. They 
reported a total of 151 lateral ankle sprains, of which 96 
were categorised as non- contact, and 50 as severe. All 
outcomes favoured Spraino with incidence rate ratios of 
0.87 (95% CI 0.62 to 1.23) for all lateral ankle sprains; 
0.64 (95% CI 0.42 to 0.98) for non- contact lateral ankle 
sprains; and 0.47 (95% CI 0.25 to 0.88) for severe 
lateral ankle sprains. Time loss per injury was also lower 
in the Spraino group (1.8 vs 2.8 weeks, p=0.014). Six 
participants reported minor harms because of Spraino.
Conclusion Compared with usual care, athletes 
allocated to Spraino had a lower risk of lateral ankle 
sprains and less time loss, with only few reported minor 
harms.
Trial registration number NCT03311490.
INTRODUCTION
A 2014 systematic review on incidence and prev-
alence of lateral ankle sprain injuries identified 
indoor sports as ‘high risk’ sports, reporting a 
pooled injury incidence rate of 7 sprains per 1000 
exposures.1 This conspicuously high incidence rate 
was highlighted in an evidence review from the 
International Ankle Consortium,2 as well as in a 
2018 clinical guideline.3
High friction between shoe and surface is a 
posited risk factor for non- contact lower limb 
injuries across various sports,4–7 and shoe–surface 
friction is generally high in indoor sports.5 The 
majority of lateral ankle sprains occur via a ‘non- 
contact’ injury mechanism,1 2 8 in which the shoe is 
only in contact with the floor, indicating that high 
shoe–surface friction is an important part of the 
injury mechanism.
Spraino is a new low- friction patch (figure 1) 
designed to prevent these ‘friction- related’ sprains 
in indoor sports by minimising friction at the 
lateral edge of the shoe sole and thus removes the 
anchoring point between shoe and floor, around 
which non- contact lateral ankle sprains typically 
occur.9 Removing that anchor reorients the vector 
of the ground reaction force (figure 2) allows the 
foot to realign more easily and prevents the rapid 
excessive inversion and internal rotation associated 
with lateral ankle sprains10 (online supplementary 
video). The first natural step following prom-
ising laboratory testing is to establish ‘proof- of- 
principle’,11 preliminary evidence of effectiveness, 
on clinically relevant endpoints. At present, it is 
unknown how Spraino might affect important clin-
ical outcomes.
Therefore, the aims of this exploratory pilot 
trial were to determine preliminary effectiveness 
and safety of using Spraino to prevent lateral ankle 
sprains among subelite indoor sport athletes with a 
previous lateral ankle sprain, when compared with 
a ‘do- as- usual’ control group.
METHODS
Design
We designed and conducted a two- arm, parallel- 
group, exploratory pilot randomised controlled 
trial to assess proof- of- principle for Spraino, being 
preliminary effectiveness and safety in lateral ankle 
sprain injury prevention among high risk indoor 
sport athletes. Participants were randomly allo-
cated (1:1) to an intervention (Spraino) group or 
a control (do- as- usual) group. The trial was regis-
tered at  ClinicalTrials. gov (NCT03311490) on 
17 October 2017 and enrolment was conducted 
between 19 October 2017 and 28 February 2018. 
The trial protocol (online supplementary appendix 
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S6) was developed using the PREPARE trial guide12 and Stan-
dard Protocol Items: Recommendations for Interventional Trials 
(SPIRIT) checklist.13 We report the trial using the Consolidated 
Standards of Reporting Trials (CONSORT) 2010 extension for 
pilot and feasibility trials.14
Participants
Participants were recruited from 91 indoor sports teams (hand-
ball, basketball and badminton) competing at divisional or league 
level in Denmark. Participants were eligible for inclusion if they: 
(1) were aged 18 years or older; (2) could read, speak and under-
stand Danish; (3) could receive and reply to text messages using 
Short Message Services (SMS); (4) performed indoor sport in a 
subelite level team with at least 2 weekly practice sessions; (5) 
had incurred at least one lateral ankle sprain in the preceding 
24 months; and (6) had returned to play at the commencement 
of our trial.
We included athletes with a previous lateral ankle sprain as 
they are at particularly ‘high risk’ of new injury,15 16 making 
injury risk mitigation pertinent. At the time of recruitment, all 
athletes were participating fully in their sport and reported no 
acute injury symptoms.
Sample size
The sample size was determined by the formula 






  where n is the number of participants in 
each arm, T the observation time, and θ0 and θ1 the incidence 
rates in the control and intervention group.17 We anticipated an 
incidence rate of 4.9 ankle sprains per 1000 hours of exposure1 
without Spraino, and an incidence rate of 2.94 per 1000 hours in 
participants randomised to Spraino (40% lower). With a power 
of 80% and an α of 5%, an exposure time of ~15 350 hours 
would be needed in each arm. Assuming an average exposure 
of 3 hours of court activities per week per participant (including 
off- season), 250 participants would be needed to be observed for 
20 weeks. Assuming a dropout rate of 15%, the 250 participants 
should be observed for at least 23 weeks.
Randomisation
Randomisation was performed after the included participants 
had provided written consent and the completed baseline ques-
tionnaires had been collected. We generated the two compar-
ison groups using balanced block randomisation. The random 
component in the sequence generation process was a drawing 
of lots. Block sizes were determined by the number of enrolled 
participants within a given team, with an equal amount of lots 
representing allocation for intervention and control being used 
to assure a 1:1 allocation ratio (ie, if a team had 9 enrolled 
players, then 10 lots, 5 representing each group (intervention 
and control), were included). The lots (wooden beads) were 
identical in appearance and drawn from an opaque bag. It was 
ensured that allocation was concealed for participants and inves-
tigators enrolling participants.
Intervention
Spraino was given to the intervention group with the purpose 
of mitigating the risk of lateral ankle sprain, while the control 
group was a do- as- usual comparator. Spraino comprises a set of 
adhesive patches, which are attached along the lateral edge of 
the shoe (figure 1). The front patch covers 2–4 mm of the shoe 
sole while the rear patch does not cover the edge (online supple-
mentary video). Spraino is intended for use in indoor sports and 
has a reported durability of 20–40 hours of activity.18
The intervention group received Spraino and application 
instructions on the same day of inclusion, along with a leaflet 
(online supplementary appendix S5) containing information on 
how to order new patches and how to report adverse events asso-
ciated with its use. They were encouraged to use Spraino during 
all indoor sport activities. Participants of both groups were also 
permitted to use (or keep using) any other injury preventive 
measure of their choice.
Patient and public involvement
Questionnaires and SMS questions were piloted and redesigned 
with help from 25 athletes. Twenty intervention group partici-
pants gave post- trial feedback on both the intervention and study 
design and conduct. The National Olympic Committee created 
awareness and helped recruit participating teams.
Figure 1 Indoor sports shoe with Spraino low- friction patches 
attached on the outside.
Figure 2 Preventive mechanism of Spraino: in case of a bad landing, 
Spraino minimises the otherwise high shoe–surface friction at the 
lateral edge of the shoe. This minimises the horizontal ground reaction 
forces (GRFs), thereby bringing the GRF vector closer towards the joint 
centre which serves to prevent excessive ankle inversion and internal 
rotation.
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Injury registration and data collection
The participants completed a baseline questionnaire19 (online 
supplementary table S2), from which mobile phone numbers were 
obtained to prospectively collect data in SMS- Track20 21 through 
answers to 6 weekly standardised questions (online supplemen-
tary figure S3).
When replying to the SMS questions, participants were 
required to report: (Q1,Q2) their weekly training and match 
exposure; (Q3) whether they had incurred a lateral ankle sprain; 
(Q4) whether their participation was restricted due to a lateral 
ankle sprain; (Q5) whether they used any ankle injury preven-
tion measure; (Q6) whether they adhered to the intervention. 
Reminder messages were sent out after 48 hours if an answer to 
a text message had not been collected. They received a reminder 
phone call if answers had not been received for two consecutive 
weeks.
If a lateral ankle sprain, or a participation restriction due to 
an ankle- related problem, was reported via the SMS system, a 
follow- up telephone interview was conducted by a member of 
the research team (online supplementary figure S3). If a lateral 
ankle sprain was incurred, a detailed injury registration form was 
completed (online supplementary table S4).
The occurrence of adverse events related to the use of Spraino 
was closely monitored by a member of the research team.
Outcome measures
Being exploratory, our trial was designed without a predetermined 
hierarchy among outcome measures. Data on contact and non- 
contact lateral ankle sprains, as well as in- trial first- time injuries 
and injury recurrences were documented. A contact sprain was 
defined as an injury incurred by stepping/landing directly onto an 
Figure 3 Consolidated Standards of Reporting Trials flow diagram.
Table 1 Baseline characteristics
Spraino Control Total
Participants, n 256 254 510
Male, n (%) 146 (57) 146 (57) 292 (57)
Age, mean (SD) 22.3 (4.0) 23.0 (4.5) 22.7 (4.3)
Height (cm), mean (SD) 181 (10) 182 (11) 182 (11)
Body mass (kg), mean (SD) 80.8 (14) 80.3 (14) 80.5 (14)
Fear*, median (IQR) 70 (40–90) 70 (50–90) 70 (40–90)
Pain†, median (IQR) 2 (0–3) 1 (0–2) 1 (0–3)
Sport, n (%)
  Handball 204 (80) 205 (81) 409 (80)
  Basketball 26 (10) 31 (12) 57 (11)
  Badminton 26 (10) 18 (7) 44 (9)
Weekly practice (hours), mean (SD) 6.1 (3.1) 6.1 (3.0) 6.1 (3.0)
Level of play, n (%)
  League 10 (4) 12 (5) 22 (4)
  First division 80 (31) 78 (31) 158 (31)
  Second division 64 (25) 70 (28) 134 (26)
  Third division 102 (40) 94 (37) 196 (38)
*Fear of ankle sprain during primary sport (100=no fear, 0=highest fear imaginable).
†Pain in ankle joint during primary sport (0=no pain, 10=highest pain imaginable).
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object (ie, opponent’s foot). A non- contact sprain was defined as 
an injury incurred without stepping onto something (other than 
the floor), regardless of any player- to- player interaction prior to 
the event. A recurrent sprain was defined as a subsequent sprain to 
the same ankle previously injured within the trial period.22 23
Time- loss following a sprain was defined as number of calendar 
weeks with time lost from unrestricted participation due to 
injury- associated symptoms,24 and was based on the response to 
Q4 (online supplementary figure S3). As such, an ankle sprain 
resulted in time- loss if: (Q4=1) the participant had reduced their 
participation in their primary sport; or (Q4=2) the participant 
was affected but still participated. A sprain was considered ‘severe’ 
if the participant experienced time- loss for more than 3 weeks.25 
Time- loss recordings for each injury was stopped on the first day 
of a consecutive 3 week period during which the participant could 
participate unrestricted in his/her primary sport to assure a causal 
link between injury and acute time- loss.
Additional outcomes included pain in the ankle joint during 
sport (NRS: 0–10)26 and fear of injury (NRS: 0–100)27 assessed 
at baseline and follow- up using numeric rating scales (NRS). The 







Total exposure (hours) 18 803 14 185
Events (151)
  Number 81 70
  
  Incidence rate† 4.30 (3.30 to 5.30) 4.93 (3.68 to 6.18) −0.62 (−2.24 to 0.99) 0.87 (0.62 to 1.23)
  Time loss (weeks) 1.8 (1.3 to 2.3) 2.8 (2.2 to 3.4) −1.0 (−1.8 to −0.2) 0.63 (0.44 to 0.92)
Non- contact events (96)
  Number 44 52
  Incidence rate† 2.33 (1.67 to 3.00) 3.67 (2.54 to 4.77) −1.38 (−2.74 to −0.02) 0.64 (0.42 to 0.98)
  Time loss (weeks) 1.9 (1.1 to 2.7) 2.7 (2.0 to 3.4) −0.9 (−2.0 to 0.2) 0.67 (0.41 to 1.10)
Severe events (50)
  Number 19 31
  Incidence rate† 1.01 (0.51 to 1.50) 2.20 (1.36 to 3.04) −1.17 (−2.13 to −0.20) 0.47 (0.25 to 0.88)
Non- contact severe events (34)
  Number 12 22
  Incidence rate† 0.63 (0.25 to 1.02) 1.56 (0.82 to 2.30) −0.89 (−1.74 to −0.04) 0.43 (0.19 to 0.97)
In- trial recurrent events (19)
Total exposure (hours) 1889 1428
  Number 10 9
  Incidence rate† 5.27 (1.68 to 8.85) 6.29 (1.81 to 10.8) −0.99 (−6.81 to 4.84) 0.85 (0.32 to 2.24)
  Time loss (weeks) 1.1 (0.5 to 1.7) 3.5 (2.1 to 4.86) −2.3 (−3.7 to −0.9) 0.33 (0.15 to 0.72)
Numbers in parenthesis represent 95% CIs.
Spraino versus control, ratio <1 indicates preventive effect.
*Incidence rate ratio or relative time- loss duration.
†Per 1000 hours of participation in primary sport.
Table 3 Fear of new ankle sprain* and pain in the ankle† at baseline and follow- up, and between- group difference for change adjusted for 
baseline values (Spraino vs control)
Mean (95% CI)
Between- group difference for changeSpraino Control
Fear*, intention to treat (n) 254 256   
  Baseline 62.9 (59.1 to 66.6) 66.6 (63.1 to 70.1)
13.7 (9.2 to 18.3)
  Follow- up 84.7 (82.2 to 87.2) 70.9 (67.2 to 74.7)
Fear*, available case (n) 146 122   
  Baseline 62.9 (59.1 to 66.6) 66.6 (63.1 to 70.1)
15.4 (10.2 to 20.7)
  Follow- up 85.0 (82.4 to 87.5) 69.5 (65.2 to 73.9)
Pain†, intention to treat (n) 254 256   
  Baseline 1.9 (1.7 to 2.1) 1.6 (1.4 to 1.8)
−1.2 (–1.5 to –0.9)
  Follow- up 0.6 (0.5 to 0.7) 1.8 (1.6 to 2.0)
Pain†, available case (n) 152 127   
  Baseline 1.9 (1.7 to 2.1) 1.6 (1.4 to 1.8)
−1.3 (–1.6 to –1.0)
  Follow- up 0.6 (0.4 to 0.7) 1.9 (1.6 to 2.2)
Numbers in parenthesis represent 95% CIs.
*Fear of sustaining a new ankle sprain during sport was measured on a scale from 100 representing no fear to 0 representing maximum fear. A change of >0 reflects less fear at follow- up as 
compared with baseline.
†Pain in the ankle during sport was measured on a scale from 0 representing no pain to 10 representing worst pain imaginable. A change of <0 reflects less pain at follow- up as compared with 
baseline.
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intervention group were instructed to report adverse events they 
associated with Spraino.
Statistical analysis
Lateral ankle sprain incidence rates per 1000 hours of exposure, 
differences and incidence rate ratios (IRRs, Spraino vs control) 
were estimated using Poisson regression with the sum of match 
play and practice hours as exposure. The effectiveness esti-
mates were adjusted for sex, age, type of sport and level of play. 
Injury recurrence was estimated similarly but only containing 
exposure from in- trial injured participants. Mean time loss for 
participants who sustained an ankle sprain was calculated using 
negative binomial regression. Robust standard errors were calcu-
lated to adjust for the repeated nature of measurements (within- 
participant correlation).
Change in fear of sustaining an ankle sprain, and change in 
ankle pain, from baseline to follow- up, were calculated using 
negative binomial regression, adjusting for the values reported 
at baseline.28 Multiple imputations by chained equations were 
performed to account for missing values.29 The imputation 
procedure included variables (age, sex, group allocation and type 
of sport) prehypothesised to potentially predict missing infor-
mation. Data were analysed using the mi estimate command in 
Stata (20 imputations) which first runs the estimation command 
on each imputation separately and then combines results using 
Rubin’s rule.30 Analyses were also conducted for participants 
with full information only (available case analysis).
Statistical analyses were conducted in Stata/IS V.13.1 and 
performed as intention to treat using inverse probability- of- 
censoring weighting to account for participant dropout.28 31 
Adhering to the intention- to- treat principle, Spraino adherence 
and cointerventions were not taken into account in the analysis. 
The outcome assessor was blinded to group allocation.
Deviations from registration
Five outcomes were not prespecified in the  ClinicalTrials. gov regis-
tration. First- time and in- trial recurrent events were combined to 
investigate (1) the overall effectiveness on injury severity (time- loss), 
(2, 3) injury mechanism (non- contact sprains and associated time 
loss), (4) rate of severe ankle sprains and (5) time loss for in- trial 
recurrences. These measures were missed in oversight during the 
registration process but added to the analysis plan (4 December 
2018) before the trial was analysed and unblinded (26 December 
2018). The full trial protocol is available as online supplementary 
appendix S6 and results of all prespecified outcomes are found in 
online supplementary table S1.
RESULTS
Recruitment and trial completion
Five hundred and ten participants were recruited and randomised 
from 1339 approached athletes of which 576 were eligible 
for inclusion (figure 3). Four hundred and eighty participants 
completed the trial: 246 in the intervention (Spraino) group and 
234 in the control (do- as- usual) group. Completion was defined 
as having responded at least once to the weekly text messages. 
Our prospective registration of injuries was originally specified 
to be conducted over a 52- week period. However, as the number 
of events required for statistical analyses was achieved sooner 
than anticipated, the trial was halted on 5 October 2018 (9 
months average follow- up). The mean number of participating 
weeks was slightly higher in the intervention group compared 
with the control group (20.7 vs 18.2 weeks).
Trial population
The mean age of participants was 22.7 years, 57% were men 
and the majority were handball players. No clinically relevant 
between- group differences appeared present (table 1) and no 
baseline hypothesis testing was undertaken, as suggested by the 
CONSORT group.14 32
Intervention effectiveness on incidence rates and incidence-
related time loss
A total of 151 lateral ankle sprains were sustained during the trial, 
of which 96 were categorised as non- contact injuries. Fifty injuries 
were categorised as severe. The injury incidence rate (sprains per 
1000 hours of exposure) was lower in the intervention (Spraino) 
group compared with the control (do- as- usual) group for all 
collected outcomes (table 2; online supplementary table S1).
The IRR was 0.87 (95% CI 0.62 to 1.23) for any type of lateral 
ankle sprain, with a mean time loss of 1.8 weeks (95% CI 1.3 to 
2.3) in the intervention (Spraino) group and 2.8 weeks (95% CI 
2.2 to 3.4) in the control (do- as- usual) group, resulting in a time- 
loss difference of 1 week (95% CI −1.8 to −0.2; table 2). The 96 
non- contact sprains occurred at a lower rate in the intervention 
group compared with the control group (IRR of 0.64; 95% CI 
0.42 to 0.98) with a time- loss difference per non- contact sprain 
of 0.9 weeks (95% CI −2.0 to 0.2). For all severe lateral ankle 
sprains, the IRR was 0.47 (95% CI 0.25 to 0.88) and for severe 
non- contact sprains the IRR was 0.43 (95% CI 0.19 to 0.97), 
both favouring the intervention group.
The 19 in- trial injury recurrences occurred at similar rate in 
the two groups (IRR of 0.85; 95% CI 0.31 to 2.34), with 2.3 
weeks (95% CI −3.7 to −0.9) less event- related time loss in the 
intervention (Spraino) group (table 2).
Intervention effectiveness on fear and pain during sport
Four hundred and fifty- five participants provided full informa-
tion on fear and pain at baseline, while 281 provided full infor-
mation at follow- up. The mean fear of sustaining an ankle sprain 
during sport decreased in both groups. A between- group differ-
ence of 13.7 points (95% CI 9.2 to 18.3) was observed (table 3). 
The mean level of pain in the ankle decreased in the intervention 
group while it increased in the control group. A between- group 
difference of −1.2 points (95% CI −1.5 to −0.9) was observed 
(table 3).
Adherence
Full adherence in the intervention group was defined as having 
reported to use Spraino for at least 75% of the week, during 
all weeks of participation. This was observed in 31 (13%) 
Table 4 Intervention- related adverse events leading to harm
Participant info Event report to hotline
Handball player, female 19 years ‘I rolled over due to the tape. Maybe it was placed 
wrong.’ (Reported as having occurred twice)
Handball player, female 20 years ‘Had a slipping incident (due to Spraino) at training 
where I fell and got some bruises. Nothing serious 
though.’
Handball player, male 22 years ‘I had an existing groin injury that I felt got worsened 
through an outwards rotation due to the tape.’
Badminton player, male 23 years ‘Rolled over twice and (I am) 100% certain it is due 
to the tape. Jumping towards my right when my foot 
slides underneath me.’ (Reported as having occurred 
twice)
Handball player, male 29 years ‘I felt that it was the tape that made me twist my 
ankle. Took it off afterwards.’
Badminton player, male 20 years ‘Made a lunge with my left leg and twisted my ankle. 
Felt like the tape increased the twist.’
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participants, while 49 (20%) reported not to have used Spraino 
at all. The 80% of the intervention group participants, who 
reported to have used Spraino, were adherent for 68% of the 
participating weeks. Treatment contamination was observed 
whereby 5 (3%) participants in the control group reported use 
of Spraino.
Harms
Six participants reported eight adverse events leading to minor 
harms during the trial (table 4). Of these, four participants expe-
rienced harm in the form of an ankle sprain.
DISCUSSION
This trial was designed to assess proof- of- principle of Spraino 
by determining preliminary effectiveness and safety in lateral 
ankle sprain injury prevention, when added to do- as- usual 
injury prevention among subelite indoor sport athletes with a 
previous sprain injury. In general, we found that Spraino had a 
protective effect across outcome measures, as the incidence rate 
of non- contact sprains and severe sprains was lower for those 
randomised to Spraino than those randomised to usual care.
Interpretation
Most of the injuries incurred in this trial occurred via a non- 
contact injury mechanism. This aligns with previously published 
literature2 8 33 and was the case for 74% (52 out of 70) of sprains 
in the control (do- as- usual) group and 54% (44 out of 81) in 
the intervention (Spraino) group. The lower incidence rate and 
proportion of non- contact sprains in the intervention group 
brings notion to the thought of excessive friction as an important 
risk factor for lower extremity injuries in sports.4–7 34
Average time loss was significantly 37% lower in the inter-
vention (Spraino) group. They returned to sports participation 
without restriction 1 week faster following injury on average, 
than did controls. For in- trial recurrent events, event- related 
time loss was 67% lower in the intervention (Spraino) group 
(1.1 vs 3.5 weeks).
The additive effectiveness of Spraino on injury incidence 
rate found in this study is comparable to the effects of other 
preventive measures (ie, exercise and external prophylactic 
measures like bracing and taping) when these are compared with 
no measure.15 That Spraino was associated with lower injury 
severity contrasts directly with the results of previous studies, 
that investigated other prophylactic measures, who found no 
reduction in time- loss per injury.35 Our results support the 
premise that Spraino can mitigate the risk of sprain injuries 
among indoor sport athletes, and that its use is not associated 
with severe adverse consequences.
The intervention (Spraino) group had 21.8 points lower fear 
of ankle sprain injuries; the between- group difference of 13.7 
points is less than minimal clinically important difference(MCID 
= 19.0)36 but could still be of some importance with persisting 
fear of injury being regarded as a major hindrance to sports 
activity.27 Pain is a frequent and debilitating problem following 
musculoskeletal injury. The between- group difference of 1.2 
points (11 NRS) in ankle pain, favouring Spraino, may not be 
clinically relevant considering an MCID of 2 points.26 However, 
our findings related to fear and pain suggest that Spraino may 
have further beneficial effects, aside from injury prevention.
Implications
Considering the high risk of both initial and recurrent ankle 
sprains in indoor sports,1 33 and with 40% of the approached 
population being eligible due to having sustained an ankle sprain 
within 24 months prior to the trial, prevention seems rele-
vant to a large population of indoor sport athletes. Clinicians 
should consider advising indoor sport athletes to use Spraino 
given its effectiveness in lowering the incidence rate of lateral 
ankle sprains, without any severe adverse consequences. Spraino 
may be particularly relevant for those athletes with subjective 
reporting of pain, fear of injury and ankle instability.37
Strengths and limitations
We acknowledge several limitations. First, not all presented 
outcomes were preregistered. These outcomes were however 
added before analysis and fit the overall pattern of Spraino 
effectiveness. Second, only passive surveillance of harms was 
used, which generally yields fewer adverse events than active 
monitoring.38 Third, participants were not blinded to the inter-
vention. This is not regarded as a limitation to the objective 
outcomes: incidence rate and time loss. However, the risk of 
bias is high on the subjective outcomes (fear and pain).
We did not control for the use of other injury prevention strat-
egies, since Spraino was introduced as an additional preventive 
measure. However, the combination of less than perfect adher-
ence to Spraino, treatment contamination and do- as- usual injury 
prevention in the control group makes the effectiveness across 
all outcomes highly promising. The intervention mirrors real life 
use of Spraino as all athletes were responsible for applying and 
replacing the product.
What are the findings?
 ► Spraino shows promising effects and appears safe when used 
to mitigate the risk of non- contact lateral ankle sprain injuries 
in indoor sport athletes.
 ► Athletes randomised to Spraino had a 53% lower incidence 
rate of severe lateral ankle sprain injuries than did the control 
athletes.
 ► Spraino seems to reduce ankle- related pain and fear of lateral 
ankle sprain injuries.
How might it impact on clinical practice in the future?
 ► Clinicians might consider recommending that indoor sports 
athletes with a previous lateral ankle sprain injury use 
Spraino.
 ► Spraino may be a relevant add- on for athletes in instances 
where previous preventive measures have been ineffective.
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